Todd Bazemore

Todd Bazemore serves as Interim Chief Executive Officer at Kala Pharmaceuticals. Kala Pharmaceuticals operates in the research sector with approximately 110.0 employees. The company is headquartered in Boston, Massachusetts. Kala Pharmaceuticals generates annual revenue of 3892000.0.

Industry & Role Insights

• • MessageCEO tracks 2,961 executives in the research sector.
• • 3,781 executive contacts are available in Massachusetts.
• • Our database includes 201,469 c suite-level executives.

Amazon CloudFront Netriplex Route 53 Mimecast Microsoft Office 365 Amazon AWS Oracle Cloud Adobe Marketing Cloud Google Tag Manager Mobile Friendly New Relic Bootstrap Framework Google Analytics Remote

biotechnology life sciences biotechnology: pharmaceutical preparations health care biotechnology research biopharmaceutical clinical-stage ophthalmic therapy mesenchymal stem cells secretome therapy kpi-012 kpi-014 dry eye disease ocular surface diseases retinal diseases persistent corneal epithelial defect limbal stem cell deficiency gene-agnostic treatments fda approval orphan drug designation fast track designation topical therapy intravitreal therapy regenerative healing therapeutic platform biologics cautions & concerns drug development cell-free therapy biologics license application vision preservation regenerative medicine wound healing ocular inflammation protease inhibitors growth factors matrix proteins clinical trials patient enrollment sight-threatening diseases ocular surgery pain commercial strategy investor relations pharmaceutical innovation clinical research biopharmaceutical industry biotechnology partnerships neuroprotective effects retinitis pigmentosa stargardt disease inherited retinal diseases ocular trauma vision restoration clinical pipeline healthcare innovation innovative therapies rare eye diseases mesenchymal stem cell secretome msc-s platform corneal healing ocular surface repair biologics-based treatments unmet medical needs ophthalmology drug delivery technology patient outcomes healthcare sector advanced science therapeutic development patient demographics competitive landscape strategic partnerships research & development transformative therapies health wellness & fitness hospital & health care

SN

Srikanth Nandiraju Chief Technology Officer at 1Cell.Ai Inc.

SD

Surinnder Dang Chief Business Officer at 1Cell.Ai Inc.

M

Mark Chief Executive Officer at 23Strands

IT

Ilia Tikhomirov Chief Executive Officer at 35Pharma

AD

Alistair Draffan Chief Executive Officer at 360biolabs Pty Ltd

Outreach Guidance — research Sector

Executives like Todd Bazemore in the research sector receive targeted outreach from sales teams, recruiters, and investors. To stand out, personalize your message with industry-specific context and a clear, specific value proposition relevant to their role at Kala Pharmaceuticals.

Todd Bazemore's Position in the MessageCEO Database

• •Todd Bazemore is 1 of 1 verified executive contact we track at Kala Pharmaceuticals.
• •2,871 verified executive contacts in research are in the MessageCEO database.
• •3,577 verified executive contacts in Massachusetts are in the database.
• •77 verified contacts work at research companies in the 110.0 employee range (same size as Kala Pharmaceuticals).

Executive contact data compiled from public business filings, LinkedIn public profiles, company press materials, and verified outbound email testing. We do not publish personal addresses or sensitive identifiers. Methodology & sources · Removal requests handled at /remove-info · Updated July 2026.

How do I reach Todd Bazemore directly?

Todd Bazemore's verified email address is available to MessageCEO Pro subscribers. They currently serve as Interim Chief Executive Officer at Kala Pharmaceuticals. Access direct contact info to skip gatekeepers and reach the decision maker.

What company does Todd Bazemore work for?

Todd Bazemore is Interim Chief Executive Officer at Kala Pharmaceuticals, a company in the research sector with 110.0 employees. The company is based in Boston, Massachusetts.

Can I pitch or sell to Todd Bazemore?

As Interim Chief Executive Officer at Kala Pharmaceuticals, Todd Bazemore is a key decision-maker in the research sector. MessageCEO Pro gives you verified email to reach Todd Bazemore directly — ideal for B2B sales, partnerships, and executive recruiting.

What industry is Todd Bazemore in?

Todd Bazemore works in the research industry as Interim Chief Executive Officer at Kala Pharmaceuticals. MessageCEO provides verified contact information for executives across all major industries.

Is Todd Bazemore's contact information verified?

Yes. MessageCEO verifies executive contact information through multiple data sources and regular validation checks. Todd Bazemore's profile is kept up-to-date with the latest available information.

Last updated: July 19, 2026